Coya Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2022 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Coya Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2022 to Q2 2024.
  • Coya Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 14.9M shares, a 49.9% increase year-over-year.
  • Coya Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 10.2M shares, a 292% increase from 2022.
  • Coya Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 2.59M shares, a 0.01% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 14.9M +4.97M +49.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 14.5M +4.74M +48.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 10.2M +7.57M +292% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 9.95M +7.36M +284% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 9.95M +7.36M +284% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 9.72M +7.13M +275% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 2.59M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 2.59M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 2.59M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 2.59M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.